Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results
|
CalciMedica, Inc. (GRAY)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
10/10/2023 |
4
| Sanderling Venture Partners VI LP (10% Owner) has filed a Form 4 on CalciMedica, Inc.
Txns:
| Granted 703,388 shares
@ $0 Granted 582,757 shares
@ $0 Granted 17,682 shares
@ $0 Granted 7,456 shares
@ $0 Granted 8,884 shares
@ $0 Granted 240,676 shares
@ $0 Granted 14,425 shares
@ $0 Granted 63,228 shares
@ $0 Granted 1,548 shares
@ $0 Granted 2,672 warrants
@ $26.74, valued at
$71.4k
Granted 16,539 warrants
@ $27.94, valued at
$462.1k
|
|
08/23/2023 |
4
| Roberts Eric W (Chief Business Officer) has filed a Form 4 on CalciMedica, Inc.
Txns:
| Bought 1,750 shares
@ $3.25, valued at
$5.7k
Bought 714 shares
@ $3.27, valued at
$2.3k
|
|
06/28/2023 |
4
| WILSON ROBERT N (Director) has filed a Form 4 on CalciMedica, Inc.
Txns:
| Granted 20,000 options to buy
@ $3.25, valued at
$65k
|
|
06/28/2023 |
4
| MIDDLETON FRED A (10% Owner) has filed a Form 4 on CalciMedica, Inc.
Txns:
| Granted 20,000 options to buy
@ $3.25, valued at
$65k
|
|
06/28/2023 |
4
| Shaw Allan (Director) has filed a Form 4 on CalciMedica, Inc.
Txns:
| Granted 20,000 options to buy
@ $3.25, valued at
$65k
|
|
06/28/2023 |
4
| BJERKHOLT ERIC (Director) has filed a Form 4 on CalciMedica, Inc.
Txns:
| Granted 20,000 options to buy
@ $3.25, valued at
$65k
|
|
06/09/2023 |
4
| MIDDLETON FRED A (10% Owner) has filed a Form 4 on CalciMedica, Inc.
Txns:
| Bought 714 shares
@ $5.2, valued at
$3.7k
|
|
06/09/2023 |
4
| Roberts Eric W (Chief Business Officer) has filed a Form 4 on CalciMedica, Inc.
Txns:
| Bought 485 shares
@ $5.2, valued at
$2.5k
|
|
06/09/2023 |
4
| Leheny A. Rachel (CEO) has filed a Form 4 on CalciMedica, Inc.
Txns:
| Bought 928 shares
@ $5.2269, valued at
$4.9k
Bought 400 shares
@ $5.25, valued at
$2.1k
|
|
06/08/2023 |
4
| MIDDLETON FRED A (10% Owner) has filed a Form 4 on CalciMedica, Inc.
Txns:
| Bought 500 shares
@ $4.8808, valued at
$2.4k
Bought 500 shares
@ $5.2, valued at
$2.6k
|
|
06/08/2023 |
4
| Roberts Eric W (Chief Business Officer) has filed a Form 4 on CalciMedica, Inc.
Txns:
| Bought 3,200 shares
@ $5.087, valued at
$16.3k
Bought 1,500 shares
@ $5.2267, valued at
$7.8k
|
|
06/08/2023 |
4
| Leheny A. Rachel (CEO) has filed a Form 4 on CalciMedica, Inc.
Txns:
| Bought 1,000 shares
@ $5.1287, valued at
$5.1k
Bought 1,000 shares
@ $5.2478, valued at
$5.2k
|
|
06/05/2023 |
4
| Leheny A. Rachel (CEO) has filed a Form 4 on CalciMedica, Inc.
Txns:
| Bought 1,000 shares
@ $4.8, valued at
$4.8k
|
|
06/05/2023 |
4
| Roberts Eric W (Chief Business Officer) has filed a Form 4 on CalciMedica, Inc.
Txns:
| Bought 2,000 shares
@ $4.415, valued at
$8.8k
Bought 1,687 shares
@ $4.9, valued at
$8.3k
|
|
06/01/2023 |
4
| Leheny A. Rachel (CEO) has filed a Form 4 on CalciMedica, Inc.
Txns:
| Bought 1,000 shares
@ $4.21, valued at
$4.2k
|
|
06/01/2023 |
4
| BJERKHOLT ERIC (Director) has filed a Form 4 on CalciMedica, Inc.
Txns:
| Bought 5 shares
@ $3.25, valued at
$16.3 Bought 100 shares
@ $4.0875, valued at
$408.8 Bought 150 shares
@ $4.2, valued at
$630 |
|
06/01/2023 |
4
| Roberts Eric W (Chief Business Officer) has filed a Form 4 on CalciMedica, Inc.
Txns:
| Bought 2,000 shares
@ $3.8616, valued at
$7.7k
|
|
05/24/2023 |
4
| BJERKHOLT ERIC (Director) has filed a Form 4 on CalciMedica, Inc.
Txns:
| Bought 500 shares
@ $3.268, valued at
$1.6k
|
|
05/24/2023 |
4
| Leheny A. Rachel (CEO) has filed a Form 4 on CalciMedica, Inc.
Txns:
| Bought 3,000 shares
@ $3.3439, valued at
$10k
|
|
05/24/2023 |
4
| Roberts Eric W (Chief Business Officer) has filed a Form 4 on CalciMedica, Inc.
Txns:
| Bought 6,000 shares
@ $2.95, valued at
$17.7k
Bought 2,000 shares
@ $3.263, valued at
$6.5k
|
|
05/18/2023 |
4
| BJERKHOLT ERIC (Director) has filed a Form 4 on CalciMedica, Inc.
Txns:
| Bought 800 shares
@ $2.7, valued at
$2.2k
Bought 200 shares
@ $2.67, valued at
$534 Bought 300 shares
@ $2.7, valued at
$810 |
|
05/18/2023 |
4
| Hebbar Sudarshan (Chief Medical Officer) has filed a Form 4 on CalciMedica, Inc.
Txns:
| Bought 10,000 shares
@ $2.6999, valued at
$27k
|
|
05/18/2023 |
4
| Roberts Eric W (Chief Business Officer) has filed a Form 4 on CalciMedica, Inc.
Txns:
| Bought 3,500 shares
@ $2.71, valued at
$9.5k
Bought 3,000 shares
@ $2.68, valued at
$8k
Bought 1,800 shares
@ $2.72, valued at
$4.9k
|
|
05/18/2023 |
4
| Leheny A. Rachel (CEO) has filed a Form 4 on CalciMedica, Inc.
Txns:
| Bought 1,000 shares
@ $2.69, valued at
$2.7k
|
|
05/10/2023 |
4
| Roberts Eric W (Chief Business Officer) has filed a Form 4 on CalciMedica, Inc.
Txns:
| Granted 60,709 options to buy
@ $3.25, valued at
$197.3k
|
|
05/10/2023 |
4
| Hebbar Sudarshan (Chief Medical Officer) has filed a Form 4 on CalciMedica, Inc.
Txns:
| Granted 60,709 options to buy
@ $3.25, valued at
$197.3k
|
|
05/10/2023 |
4
| Dunn Michael J. (President and COO) has filed a Form 4 on CalciMedica, Inc.
Txns:
| Granted 55,190 options to buy
@ $3.25, valued at
$179.4k
|
|
05/10/2023 |
4
| Stauderman Kenneth A. (Chief Scientific Officer) has filed a Form 4 on CalciMedica, Inc.
Txns:
| Granted 68,988 options to buy
@ $3.25, valued at
$224.2k
|
|
05/10/2023 |
4
| Leheny A. Rachel (CEO) has filed a Form 4 on CalciMedica, Inc.
Txns:
| Granted 110,380 options to buy
@ $3.25, valued at
$358.7k
|
|
05/03/2023 |
4
| Geffken Daniel E. (Interim CFO) has filed a Form 4 on CalciMedica, Inc.
Txns:
| Granted 11,520 warrants
@ $6.6, valued at
$76k
Granted 5,760 warrants
@ $10.42, valued at
$60k
|
|
05/03/2023 |
4
| Valence Investments SPV IV LLC (10% Owner) has filed a Form 4 on CalciMedica, Inc.
Txns:
| Granted 356,989 shares
@ $0 Granted 66,228 shares
@ $0 Granted 316,109 shares
@ $0 Granted 9,935 warrants
@ $27.94, valued at
$277.6k
|
|
03/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|